Total Payments
$2,984
2024 Payments
$306.99
Companies
27
Transactions
138
Medicare Patients
2,718
Medicare Billing
$730,630
Payment Breakdown by Category
Food & Beverage$2,886 (96.7%)
Education$98.85 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,886 | 135 | 96.7% |
| Education | $98.85 | 3 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $528.93 | 13 | $0 (2024) |
| Amgen Inc. | $386.71 | 19 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $303.56 | 18 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $254.61 | 8 | $0 (2022) |
| Relypsa, Inc. | $198.38 | 14 | $0 (2020) |
| Fresenius USA Marketing, Inc. | $135.69 | 8 | $0 (2022) |
| AbbVie Inc. | $119.97 | 1 | $0 (2023) |
| Keryx Biopharmaceuticals, Inc. | $119.79 | 7 | $0 (2018) |
| GENZYME CORPORATION | $116.68 | 7 | $0 (2022) |
| AKEBIA THERAPEUTICS INC | $115.61 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $306.99 | 5 | AstraZeneca Pharmaceuticals LP ($262.65) |
| 2023 | $195.84 | 6 | AbbVie Inc. ($119.97) |
| 2022 | $314.66 | 14 | Bayer HealthCare Pharmaceuticals Inc. ($81.04) |
| 2021 | $193.30 | 10 | AstraZeneca Pharmaceuticals LP ($77.12) |
| 2020 | $174.23 | 10 | Amgen Inc. ($44.75) |
| 2019 | $766.23 | 30 | Alexion Pharmaceuticals, Inc. ($194.43) |
| 2018 | $542.74 | 31 | Amgen Inc. ($79.39) |
| 2017 | $490.37 | 32 | Relypsa, Inc. ($141.22) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $68.95 | General |
| Category: Respiratory | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $68.70 | General |
| Category: Respiratory | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 02/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 01/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: Inflammation | ||||||
| 11/27/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Inflammation | ||||||
| 09/26/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: RESPIRATORY | ||||||
| 08/17/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $119.97 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $17.57 | General |
| Category: NEPHROLOGY | ||||||
| 03/16/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Nephrology | ||||||
| 02/23/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: NEPHROLOGY | ||||||
| 07/05/2022 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Genetic Disease | ||||||
| 06/21/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: IMMUNOLOGY | ||||||
| 05/25/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Cardio-renal | ||||||
| 05/10/2022 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $18.59 | General |
| 04/20/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 04/12/2022 | Amgen Inc. | Tavneos (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Not Applicable | ||||||
| 03/30/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Cardio-renal | ||||||
| 03/15/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/14/2022 | Amgen Inc. | Tavneos (Drug) | Education | In-kind items and services | $20.08 | General |
| Category: Not Applicable | ||||||
| 03/01/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Nephrology | ||||||
| 02/16/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $51.56 | General |
| Category: Cardio-renal | ||||||
| 02/15/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $31.43 | General |
| Category: Nephrology | ||||||
| 02/01/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Rare Disease | ||||||
| 01/04/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Phosphate binder for ESRD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 211 | 284 | $88,632 | $27,430 |
| 2022 | 7 | 395 | 860 | $161,296 | $112,791 |
| 2021 | 15 | 880 | 2,131 | $384,153 | $257,938 |
| 2020 | 16 | 1,232 | 3,198 | $565,623 | $332,472 |
Total Patients
2,718
Total Services
6,473
Medicare Billing
$730,630
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 145 | $35,257 | $10,681 | 30.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 21 | 24 | $20,760 | $6,484 | 31.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 20 | 20 | $14,300 | $4,487 | 31.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 48 | $9,018 | $2,928 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $5,904 | $1,740 | 29.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 29 | $3,393 | $1,110 | 32.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 51 | 256 | $96,000 | $71,094 | 74.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 144 | 355 | $28,400 | $19,382 | 68.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 110 | $15,950 | $9,303 | 58.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 23 | 33 | $11,550 | $7,418 | 64.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 34 | 35 | $8,750 | $5,357 | 61.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 45 | 55 | $550.00 | $189.45 | 34.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 15 | 16 | $96.00 | $47.43 | 49.4% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 71 | 482 | $178,575 | $135,103 | 75.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 275 | 913 | $73,640 | $51,055 | 69.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 147 | 244 | $34,160 | $22,347 | 65.4% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 41 | 70 | $24,500 | $16,276 | 66.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 93 | 96 | $24,000 | $14,953 | 62.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 34 | 40 | $7,220 | $5,500 | 76.2% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 43 | 80 | $14,000 | $4,466 | 31.9% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 17 | 19 | $6,650 | $2,853 | 42.9% |
| 90937 | Hemodialysis procedure with repeated evaluations | Facility | 2021 | 20 | 34 | $13,600 | $2,797 | 20.6% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 19 | 19 | $1,900 | $1,485 | 78.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 15 | $1,240 | $466.05 | 37.6% |
| G2251 | Brief communication technology-based service, e.g. virtual check-in, by a qualified health care professional who cannot report evaluation and management services, provided to an established patient, not originating from a related service provided within th | Office | 2021 | 42 | 51 | $4,080 | $396.72 | 9.7% |
About Dr. Scott Sims, M.D
Dr. Scott Sims, M.D is a Nephrology healthcare provider based in Bowling Green, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568425106.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Sims, M.D has received a total of $2,984 in payments from pharmaceutical and medical device companies, with $306.99 received in 2024. These payments were reported across 138 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,886).
As a Medicare-enrolled provider, Sims has provided services to 2,718 Medicare beneficiaries, totaling 6,473 services with total Medicare billing of $730,630. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Bowling Green, KY
- Active Since 04/06/2006
- Last Updated 03/09/2023
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1568425106
Products in Payments
- LOKELMA (Drug) $235.86
- Veltassa (Drug) $217.45
- BREZTRI (Drug) $193.70
- Parsabiv (Biological) $161.64
- Auryxia (Drug) $155.99
- JYNARQUE (Drug) $152.06
- SAMSCA (Drug) $151.50
- ACTHAR (Biological) $124.66
- Velphoro (Drug) $122.39
- VRAYLAR (Drug) $119.97
- Kerendia (Drug) $100.26
- Parsabiv (Drug) $96.67
- AURYXIA (Drug) $79.41
- AIRSUPRA (Drug) $68.95
- FABRY-DISEASE (Drug) $66.47
- ENTRESTO (Drug) $60.04
- SOLIRIS (Drug) $53.01
- Sensipar (Drug) $51.93
- KRYSTEXXA (Drug) $51.16
- Rituxan (Biological) $49.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.